Literature DB >> 7660248

Epidemiology of and risk factors for pancreatic cancer.

E B Gold1.   

Abstract

In the United States, incidence of and mortality from pancreatic cancer increased for several decades earlier in this century but have tended to level off in recent years. Rates increase with age and are higher in blacks than in whites and higher in males than in females. No consistent differences by socioeconomic status or by geographic location in the United States have been identified, although international variation and differences in migrants have been observed. Thus, both genetic and environmental factors may be playing significant roles in the development of pancreatic cancer. Cigarette smoking increases the risk of pancreatic cancer, but the strength of this association is much less than for lung cancer or other smoking-related cancers. Epidemiologic studies of the effect of alcohol consumption on pancreatic cancer largely show no relationship, and the results for coffee consumption indicate little, if any, association. Human studies have suggested positive associations with meat consumption and carbohydrate intake and a protective effect of dietary fiber and consumption of fruits and vegetables. Results of a number of occupational studies are suggestive of increased risk associated with some exposures but are not fully consistent. Thus, much progress has been made in the last two decades in identifying risk factors, but much epidemiologic work is needed to identify and reduce putative exposures.

Entities:  

Mesh:

Year:  1995        PMID: 7660248     DOI: 10.1016/s0039-6109(16)46730-7

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  13 in total

Review 1.  Ethnic disparity of pancreatic cancer in New Zealand.

Authors:  Anthony R J Phillips; Carlene M M Lawes; Garth J S Cooper; John A Windsor
Journal:  Int J Gastrointest Cancer       Date:  2002

2.  Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

3.  Screening for pancreatic cancer: current evidence and future directions.

Authors:  Julia B Greer; Randall E Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

4.  A comparison of stage of presentation for pancreatic and colorectal cancer in Pennsylvania 2000-2005.

Authors:  Mark Chirumbole; Niraj Gusani; Alicia Howard; Tim Leonard; Peter Lewis; Josh Muscat
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

Review 5.  Pancreatic cancer: can we screen? How should we stage?

Authors:  A A Parikh; A M Lowy
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 6.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

Review 7.  Pancreatic adenocarcinoma: epidemiology and genetics.

Authors:  T Y Flanders; W D Foulkes
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

8.  Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases.

Authors:  Apar Kishor Ganti; Anil Potti; Michael Koch; Ketki Tendulkar; David Hanekom; Vijay Koka; Ralph Levitt
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

9.  Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality.

Authors:  T A Gordon; H M Bowman; J M Tielsch; E B Bass; G P Burleyson; J L Cameron
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.

Authors:  Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.